A sheep model for thoracic aortic surgery in the presence of systemic coagulopathy.
Surgical repair of aneurysms, traumatic injuries, or congenital anomalies of the thoracic aorta are associated with high morbidity and mortality mainly as a result of excessive and uncontrollable hemorrhage from diffuse coagulopathy. We developed a model in sheep that simulates this coagulopathic state for experimentation with thoracic aorta surgery. This experimental animal model involves administering a 600-mg aspirin suppository once a day for the 2 days preceding surgery and a final dose on-call to surgery. Prior to cross-clamping the aorta, an intravenous (i.v.) bolus of heparin (400 IU/kg) was administered. Thirty minutes later, the i.v. heparin bolus was repeated. Pre- and intraoperative activated clotting time was 101 +/- 10 s and >1500 s (p < .0001); prothrombin time, 21 +/- 1 s and >100 s (p < .0001); and activated partial thromboplastin time, 20 +/- 1 s and >50 s (p < .0001), respectively. We utilized a partial cross-clamp-and-sew technique to anastomose a woven, gelatin-impregnated, 16-mm tube graft end-to-side to the descending thoracic aorta. Mean total blood loss was 1367 +/- 282 mL, which included mean blood loss from time of release of aortic cross-clamp to close (422 +/- 135 mL) and mean total blood output from chest tube drain (945 +/- 203 mL). The mean time to achieve hemostasis at suture lines after aortic cross-clamp release was 15.5 +/- 6.6 min. In conclusion, a sheep model with induced coagulation defects was successfully developed and reproducible for experimentation involving thoracic aortic surgery.
Tran
H S
HS
Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Cooper Hospital/University Medical Center, Camden, USA.
Chrzanowski
F A
FA
Puc
M M
MM
Marra
S W
SW
Cilley
J H
JH
Malli
D
D
Patel
N
N
Hewitt
C W
CW
DelRossi
A J
AJ
D000714:Anastomosis, Surgical; D000818:Animals; D000925:Anticoagulants; D001013:Aorta, Thoracic / Q000601:surgery*; D001778:Blood Coagulation Disorders / Q000503:physiopathology*; D016063:Blood Loss, Surgical; D004195:Disease Models, Animal; D006493:Heparin; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time; D012756:Sheep; D013525:Surgical Instruments
D000925:Anticoagulants; D006493:Heparin